Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 94701-94750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05055323
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
PHASE1Active, not recruiting
20 participants
Started: Jul 29, 2021 · Completed: Dec 31, 2026
8 conditions1 sponsor1 location
NCT04883242
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
30 participants
Started: Jul 29, 2021 · Completed: Dec 31, 2031
2 conditions2 sponsors1 location
NCT07217184
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jul 29, 2021 · Completed: Mar 11, 2027
1 condition1 sponsor19 locations
NCT04666610
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
PHASE3Recruiting
160 participants
Started: Jul 29, 2021 · Completed: Feb 25, 2027
2 conditions1 sponsor53 locations
NCT06868667
Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
PHASE3Active, not recruiting
24 participants
Started: Jul 28, 2021 · Completed: Jun 19, 2026
1 condition1 sponsor16 locations
NCT05387070
PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
PHASE3Recruiting
76 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05000827
Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
NARecruiting
706 participants
Started: Jul 28, 2021 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT05275101
Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy
NAActive, not recruiting
191 participants
Started: Jul 28, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04984291
Zimmer Biomet Shoulder Arthroplasty PMCF
NARecruiting
584 participants
Started: Jul 28, 2021 · Completed: Aug 15, 2033
6 conditions1 sponsor17 locations
NCT04885244
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery
N/ARecruiting
500 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2034
4 conditions2 sponsors12 locations
NCT06868654
China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
PHASE3Active, not recruiting
72 participants
Started: Jul 28, 2021 · Completed: Jun 19, 2026
1 condition1 sponsor11 locations
NCT04786067
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
PHASE4Recruiting
25 participants
Started: Jul 28, 2021 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT05006937
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
NARecruiting
168 participants
Started: Jul 28, 2021 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT04817618
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
PHASE3Recruiting
98 participants
Started: Jul 28, 2021 · Completed: Jul 4, 2026
1 condition1 sponsor81 locations
NCT05206227
Histamine as a Molecular Transducer of Adaptation to Exercise
EARLY_PHASE1Recruiting
80 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04945785
" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
N/AActive, not recruiting
226 participants
Started: Jul 28, 2021 · Completed: May 28, 2026
1 condition1 sponsor1 location
NCT04843982
Immunoinflammatory Regulation of Esketamine in Septic Patients
PHASE4Recruiting
100 participants
Started: Jul 28, 2021 · Completed: Oct 30, 2026
4 conditions1 sponsor2 locations
NCT05004493
Biorepository and Registry for Plasma Exchange Patients
N/ARecruiting
200 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2040
4 conditions1 sponsor1 location
NCT04814108
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
PHASE2Recruiting
76 participants
Started: Jul 28, 2021 · Completed: May 31, 2025
1 condition1 sponsor52 locations
NCT04145141
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
N/ARecruiting
500 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor7 locations
NCT05065060
Parkinson Progression Marker Initiative Online (PPMI Online)
N/ARecruiting
500,000 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2041
1 condition1 sponsor1 location
NCT05361707
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
PHASE3Recruiting
100 participants
Started: Jul 28, 2021 · Completed: Jul 31, 2025
4 conditions1 sponsor5 locations
NCT04551482
Oxytocin for Weight Loss in Adolescents
PHASE2Recruiting
75 participants
Started: Jul 28, 2021 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT04959526
Shear-wave Elastography Compared to Respiratory Function Testing
NARecruiting
24 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05178368
MRI in Randomised Cohorts of Asymptomatic AS
N/ARecruiting
230 participants
Started: Jul 28, 2021 · Completed: Sep 1, 2031
1 condition2 sponsors1 location
NCT04949256
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
PHASE3Active, not recruiting
863 participants
Started: Jul 28, 2021 · Completed: Jan 31, 2027
1 condition2 sponsors198 locations
NCT04798781
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
PHASE2Active, not recruiting
16 participants
Started: Jul 28, 2021 · Completed: Feb 14, 2026
2 conditions2 sponsors3 locations
NCT04713800
Two-unit Cantilever Implant Prostheses Made of Monolithic Zirconia or PFM
NARecruiting
38 participants
Started: Jul 28, 2021 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT04401007
Erector Spinae Plane (ESP) Block Volunteer Study
NAActive, not recruiting
24 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04897516
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
PHASE3Recruiting
300 participants
Started: Jul 28, 2021 · Completed: Dec 1, 2026
1 condition2 sponsors6 locations
NCT04779970
COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections
NAActive, not recruiting
156 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors26 locations
NCT05177237
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
PHASE2Recruiting
30 participants
Started: Jul 28, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04967365
Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study
N/AActive, not recruiting
755 participants
Started: Jul 27, 2021 · Completed: Jun 30, 2026
2 conditions3 sponsors30 locations
NCT05533099
REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up
N/AActive, not recruiting
14 participants
Started: Jul 27, 2021 · Completed: May 17, 2026
1 condition2 sponsors1 location
NCT04913064
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
NARecruiting
26 participants
Started: Jul 27, 2021 · Completed: Jan 12, 2026
1 condition2 sponsors1 location
NCT04786093
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
PHASE2Active, not recruiting
52 participants
Started: Jul 27, 2021 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT04923932
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
PHASE2Active, not recruiting
75 participants
Started: Jul 27, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04943497
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
N/ARecruiting
3,290 participants
Started: Jul 27, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor40 locations
NCT04747613
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE3Active, not recruiting
208 participants
Started: Jul 27, 2021 · Completed: Oct 19, 2027
1 condition1 sponsor57 locations
NCT04635189
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
PHASE2Active, not recruiting
28 participants
Started: Jul 27, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04781972
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
PHASE4Recruiting
30 participants
Started: Jul 27, 2021 · Completed: Apr 30, 2029
1 condition2 sponsors1 location
NCT03672279
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
N/ARecruiting
100 participants
Started: Jul 27, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04950894
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NAActive, not recruiting
150 participants
Started: Jul 27, 2021 · Completed: Oct 30, 2025
7 conditions1 sponsor20 locations
NCT04905277
Atenolol for the Prevention of Osteoporosis (APO)
PHASE2Active, not recruiting
420 participants
Started: Jul 27, 2021 · Completed: Mar 31, 2026
1 condition4 sponsors3 locations
NCT05112913
Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years
PHASE4Active, not recruiting
2,520 participants
Started: Jul 27, 2021 · Completed: Dec 25, 2023
1 condition1 sponsor1 location
NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
PHASE3Enrolling by invitation
760 participants
Started: Jul 27, 2021 · Completed: Aug 7, 2030
1 condition1 sponsor97 locations
NCT05174247
Addition of FFRct in the Diagnostic Pathway of Patients With Stable Chest Pain
NARecruiting
528 participants
Started: Jul 27, 2021 · Completed: Jul 15, 2025
2 conditions1 sponsor1 location
NCT05008965
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
PHASE2Recruiting
100 participants
Started: Jul 27, 2021 · Completed: Jun 30, 2024
1 condition2 sponsors16 locations
NCT04813185
Preventing Retaliatory Gun Violence in Violently Injured Adults
NARecruiting
616 participants
Started: Jul 27, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06924125
Spanish Natural History Study for LAMA2 Muscular Dystrophy
N/ARecruiting
100 participants
Started: Jul 27, 2021 · Completed: Jul 1, 2030
5 conditions2 sponsors1 location